• PRODUCT AVAILABILITY: Did you know you can view a product's availability right on the product page? Simply enter the quantity you want to purchase and the current availability will appear below the item.

  • Product is restricted and can only be purchased by customers with a web profile linked to a Thomas Business Account - Click here to login or create your web profile. If you do not have a Thomas Business Account, please Contact Us and someone will respond with details on how to apply for a business account with us.

MilliporeSigma

Lumefantrine United States Pharmacopeia (USP) Reference Standard

Not yet rated

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Synonyms: (9Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-alpha-[(dibutylamino)methyl]-9H-fluorene-4-methanol; Benflumetol; CPG-56695

Molecular Formula: C30H32Cl3NO

Molecular Weight: 528.94

Linear Structural Formula: C30H32Cl3NO

MDL Number: MFCD05662268

Storage: 15-25C

Biochem Physiol Actions: Lumefantrine is is an antimalarial for the treatment of multi-drug resistant strains of falciparum malaria.

Other Notes: USP issued SDS can be found here.

Please Enter Your Order Info

Filter by:

  • Clear Filters
Product Detail
Thomas No.
CHM02V454
Mfr. No.
1370746-100MG
Description
1370746-100MG, Lumefantrine United States Pharmacopeia (USP) Reference Standard
CAS Number
82186-77-4
list price/quantitytotal
$0.00
$0.00 (0 Items)
Product is restricted and can only be purchased by customers with a web profile linked to a Thomas Business Account - Click here to login or create your web profile. If you do not have a Thomas Business Account, please Contact Us and someone will respond with details on how to apply for a business account with us.

Write A Review